title: Hormone replacement therapy and vascular risk disorders in adult hypopituitarism.
abstract: Adult patients with hypopituitarism are treated by the replacement of deficient hormones, although GH has not been substituted until March 2006 in Japan except for clinical trial. This study examines which hormonal status influences the prevalence of vascular risk disorders in hypopituitary adults. A sample of 263 adult patients with hypopituitarism was studied, among whom there were various hormonal status such as no deficiency, treated or untreated deficiency of each pituitary hormone. Analysis of adult patients with hypopituitarism showed that hypertension was more prevalent in the older than in younger patients and in male than in female patients. Hypercholesterolemia and hypertriglyceridemia were more prevalent in patients with TSH deficiency even with thyroxine substitution than those without TSH deficiency. Both obesity and hypertension were less prevalent in patients with treated ACTH deficiency than those without ACTH deficiency. Obesity was more prevalent in patients with treated vasopressin deficiency than those without vasopressin deficiency. These results provide evidence that glucocorticoid substitution in ACTH deficient adults was favorable to prevent obesity and hypertension but that the thyroxine substitution in TSH deficient adults appeared rather insufficient to prevent hyperlipidemia.
authors.affiliation: Division of Physiology/Metabolism, University of Hyogo, Japan.
authors.forename: Hidesuke
authors.initials: H
authors.lastname: Kaji
authors.forename: Keiji
authors.initials: K
authors.lastname: Iida
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Okimura
authors.forename: Kazauo
authors.initials: K
authors.lastname: Chihara
mesh_terms: D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000172:deficiency; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology / Q000209:etiology; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology; D015228:Hypertriglyceridemia / Q000453:epidemiology / Q000209:etiology; D007018:Hypopituitarism / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology / Q000209:etiology; D015995:Prevalence; D012307:Risk Factors; D017678:Sex Distribution; D013972:Thyrotropin / Q000172:deficiency; D013974:Thyroxine / Q000627:therapeutic use; D014652:Vascular Diseases / Q000453:epidemiology / Q000209:etiology*; D014667:Vasopressins / Q000172:deficiency
chemical_list: D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013974:Thyroxine